Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 144

1.

Profound changes in dopaminergic neurotransmission in the prefrontal cortex in response to flattening of the diurnal glucocorticoid rhythm: implications for bipolar disorder.

Minton GO, Young AH, McQuade R, Fairchild G, Ingram CD, Gartside SE.

Neuropsychopharmacology. 2009 Sep;34(10):2265-74. doi: 10.1038/npp.2009.53. Epub 2009 Jun 3.

2.

Maternal high-fat intake alters presynaptic regulation of dopamine in the nucleus accumbens and increases motivation for fat rewards in the offspring.

Naef L, Moquin L, Dal Bo G, Giros B, Gratton A, Walker CD.

Neuroscience. 2011 Mar 10;176:225-36. doi: 10.1016/j.neuroscience.2010.12.037. Epub 2010 Dec 25.

PMID:
21187125
3.
4.

Influence of glucocorticoids on dopaminergic transmission in the rat dorsolateral striatum.

Barrot M, Abrous DN, Marinelli M, Rougé-Pont F, Le Moal M, Piazza PV.

Eur J Neurosci. 2001 Feb;13(4):812-8. Erratum in: Eur J Neurosci 2001 May;13(10):2013.

PMID:
11207816
5.

Early Antipsychotic Treatment in Juvenile Rats Elicits Long-Term Alterations to the Dopamine Neurotransmitter System.

De Santis M, Lian J, Huang XF, Deng C.

Int J Mol Sci. 2016 Nov 22;17(11). pii: E1944.

6.
7.

Effects of neonatal ventral hippocampal lesion in rats on stress-induced acetylcholine release in the prefrontal cortex.

Laplante F, Stevenson CW, Gratton A, Srivastava LK, Quirion R.

J Neurochem. 2004 Dec;91(6):1473-82.

8.

Dopamine D2 and serotonin 5-HT1A receptors mediate the actions of aripiprazole in mesocortical and mesoaccumbens transmission.

Tanahashi S, Yamamura S, Nakagawa M, Motomura E, Okada M.

Neuropharmacology. 2012 Feb;62(2):765-74. doi: 10.1016/j.neuropharm.2011.08.031. Epub 2011 Sep 10.

PMID:
21925189
10.

Antidepressant-like effects of the glucocorticoid receptor antagonist RU-43044 are associated with changes in prefrontal dopamine in mouse models of depression.

Ago Y, Arikawa S, Yata M, Yano K, Abe M, Takuma K, Matsuda T.

Neuropharmacology. 2008 Dec;55(8):1355-63. doi: 10.1016/j.neuropharm.2008.08.026. Epub 2008 Aug 30.

PMID:
18796307
11.

Glucocorticoid effects on mesotelencephalic dopamine neurotransmission.

Lindley SE, Bengoechea TG, Schatzberg AF, Wong DL.

Neuropsychopharmacology. 1999 Sep;21(3):399-407.

12.

Repeated exposure to the herbicide atrazine alters locomotor activity and the nigrostriatal dopaminergic system of the albino rat.

Rodríguez VM, Limón-Pacheco JH, Mendoza-Trejo MS, González-Gallardo A, Hernández-Plata I, Giordano M.

Neurotoxicology. 2013 Jan;34:82-94. doi: 10.1016/j.neuro.2012.10.012. Epub 2012 Nov 2.

PMID:
23123945
13.

Suppression of glucocorticoid secretion and antipsychotic drugs have similar effects on the mesolimbic dopaminergic transmission.

Piazza PV, Barrot M, Rougé-Pont F, Marinelli M, Maccari S, Abrous DN, Simon H, Le Moal M.

Proc Natl Acad Sci U S A. 1996 Dec 24;93(26):15445-50.

14.

Altered glucocorticoid rhythm attenuates the ability of a chronic SSRI to elevate forebrain 5-HT: implications for the treatment of depression.

Gartside SE, Leitch MM, Young AH.

Neuropsychopharmacology. 2003 Sep;28(9):1572-8. Epub 2003 May 14.

15.

Activation of glutamate neurotransmission in the prefrontal cortex sustains the motoric and dopaminergic effects of phencyclidine.

Takahata R, Moghaddam B.

Neuropsychopharmacology. 2003 Jun;28(6):1117-24. Epub 2003 Mar 26.

16.

Flattening the corticosterone rhythm attenuates 5-HT1A autoreceptor function in the rat: relevance for depression.

Leitch MM, Ingram CD, Young AH, McQuade R, Gartside SE.

Neuropsychopharmacology. 2003 Jan;28(1):119-25.

17.

Estradiol and isotype-selective estrogen receptor agonists modulate the mesocortical dopaminergic system in gonadectomized female rats.

Sárvári M, Deli L, Kocsis P, Márk L, Maász G, Hrabovszky E, Kalló I, Gajári D, Vastagh C, Sümegi B, Tihanyi K, Liposits Z.

Brain Res. 2014 Oct 2;1583:1-11. doi: 10.1016/j.brainres.2014.06.020. Epub 2014 Jun 26.

PMID:
24976584
18.

Stimulation by neurotensin of dopamine and 5-hydroxytryptamine (5-HT) release from rat prefrontal cortex: possible role of NTR1 receptors in neuropsychiatric disorders.

Petkova-Kirova P, Rakovska A, Zaekova G, Ballini C, Corte LD, Radomirov R, Vágvölgyi A.

Neurochem Int. 2008 Dec;53(6-8):355-61. doi: 10.1016/j.neuint.2008.08.010. Epub 2008 Sep 12.

PMID:
18835308
20.

Genetic deletion of vesicular monoamine transporter-2 (VMAT2) reduces dopamine transporter activity in mesencephalic neurons in primary culture.

Yamamoto H, Kamegaya E, Hagino Y, Imai K, Fujikawa A, Tamura K, Enokiya T, Yamamoto T, Takeshima T, Koga H, Uhl GR, Ikeda K, Sora I.

Neurochem Int. 2007 Jul-Sep;51(2-4):237-44. Epub 2007 Jun 29.

PMID:
17664021

Supplemental Content

Support Center